Terms: = Lung cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Staging
8 results:
1. Impact of High-Grade Patterns in Early-Stage lung Adenocarcinoma: A Multicentric Analysis.
Bertoglio P; Aprile V; Ventura L; Cattoni M; Nachira D; Lococo F; Perez MR; Guerrera F; Minervini F; Querzoli G; Bocchialini G; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Bogina GS; Solli P; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Gnetti L; Terzi AC
Lung; 2022 Oct; 200(5):649-660. PubMed ID: 35988096
[TBL] [Abstract] [Full Text] [Related]
2. [Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].
;
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):882-890. PubMed ID: 34344071
[No Abstract] [Full Text] [Related]
3. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell lung cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort.
Evison M; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Hiley C; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):145-154. PubMed ID: 32978027
[TBL] [Abstract] [Full Text] [Related]
4. Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.
Casal RF; Sepesi B; Sagar AS; Tschirren J; Chen M; Li L; Sunny J; Williams J; Grosu HB; Eapen GA; Jimenez CA; Ost DE
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819811
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of T categories for pure ground-glass nodules with semi-automatic volumetry: is mass a better predictor of invasive part size than other volumetric parameters?
Kim H; Goo JM; Park CM
Eur Radiol; 2018 Oct; 28(10):4288-4295. PubMed ID: 29713766
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract] [Full Text] [Related]
7. Heterogeneity of clinical n1 non-small cell lung cancer.
Kim D; Choi YS; Kim HK; Kim K; Kim J; Shim YM
Thorac Cardiovasc Surg; 2014 Mar; 62(2):103-8. PubMed ID: 23319312
[TBL] [Abstract] [Full Text] [Related]
8. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
Chest; 2000 Feb; 117(2):346-53. PubMed ID: 10669673
[TBL] [Abstract] [Full Text] [Related]
